Novo CEO pressed by Senate to chop selling prices of obesity, diabetes drugs CEO Lars Fruergaard Jørgensen instructed lawmakers the corporation would take into consideration new talks with insurers in regards to the checklist prices of Wegovy and copyright if they pledge to help keep the medicines on their own https://daves-hot-chicken-nutriti63837.bloggactivo.com/30126778/the-ultimate-guide-to-healthcare-news